BRPI0812311A2 - Uso de um peptídeo derivado da proteína e2, e6 e/ou e7 do hpv - Google Patents

Uso de um peptídeo derivado da proteína e2, e6 e/ou e7 do hpv

Info

Publication number: BRPI0812311A2
Authority: BR; Brazil
Prior art keywords: hpv; protein derived; derived peptide; peptide; protein
Prior art date: 2007-05-31

Application number

BRPI0812311-0A2A

Other languages

English (en)

Inventor

Sjoerd Henricus Van Der Burg

Gemma G Kenter

Cornelis Johannes Maria Malief

Original Assignee

Academish Ziekenhuis Liden H O D N Lumc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-31

Filing date

2008-05-27

Publication date

2014-10-29

2008-05-27 Application filed by Academish Ziekenhuis Liden H O D N Lumc filed Critical Academish Ziekenhuis Liden H O D N Lumc

2014-10-29 Publication of BRPI0812311A2 publication Critical patent/BRPI0812311A2/pt

2019-02-05 Publication of BRPI0812311A8 publication Critical patent/BRPI0812311A8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Mycology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)

BRPI0812311A 2007-05-31 2008-05-27 uso de um peptídeo derivado da proteína e2, e6 e/ou e7 do hpv BRPI0812311A8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94107007P	2007-05-31	2007-05-31
EP07109287		2007-05-31
PCT/NL2008/050315 WO2009002159A2 (en)	2007-05-31	2008-05-27	Intradermal hpv peptide vaccination

Publications (2)

Publication Number	Publication Date
BRPI0812311A2 true BRPI0812311A2 (pt)	2014-10-29
BRPI0812311A8 BRPI0812311A8 (pt)	2019-02-05

Family

ID=38477016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0812311A BRPI0812311A8 (pt)	2007-05-31	2008-05-27	uso de um peptídeo derivado da proteína e2, e6 e/ou e7 do hpv

Country Status (10)

Country	Link
US (2)	US9562075B2 (pt)
EP (1)	EP2155240B1 (pt)
JP (2)	JP2010530362A (pt)
CN (1)	CN101795705A (pt)
AU (1)	AU2008269721B2 (pt)
BR (1)	BRPI0812311A8 (pt)
CA (1)	CA2688589A1 (pt)
ES (1)	ES2482192T3 (pt)
MX (1)	MX2009012922A (pt)
WO (1)	WO2009002159A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN105031610B (zh) *	2007-05-31	2020-06-19	莱顿教学医院	侵润宫颈恶性肿瘤的t细胞所靶向的用于疫苗的hpv表位
WO2010027973A1 (en) *	2008-09-02	2010-03-11	Antigen Express, Inc.	Human papillomavirus / li-key hybrids and methods of use
CA2819416C (en)	2010-12-02	2019-04-30	Bionor Immuno As	Peptide scaffold design
EP2883550A1 (en) *	2013-12-12	2015-06-17	Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts	Novel promiscuous HPV16-derived T helper epitopes for immunotherapy
CN108289913A (zh)	2015-10-30	2018-07-17	儿童国家医疗中心	从未致敏t细胞群体产生hpv抗原特异性t细胞
JP6989134B2 (ja)	2015-11-18	2022-01-05	イミューノヴァクシーンテクノロジーズインコーポレイテッドImmunovaccine Technologies Inc.	ポリｉ：ｃポリヌクレオチドアジュバント及び脂質系アジュバントを含むアジュバント系及び水を含まないワクチン組成物
CA3027459A1 (en) *	2016-06-20	2017-12-28	Isa Pharmaceuticals B.V.	Formulation of a peptide vaccine
US11524063B2 (en) *	2017-11-15	2022-12-13	Arizona Board Of Regents On Behalf Of Arizona State University	Materials and methods relating to immunogenic epitopes from human papillomavirus
JP7595827B2 (ja) *	2018-03-12	2024-12-09	ステムセルテクノロジーズカナダインコーポレーテッド	免疫応答を改変するための生体分子の細胞内送達
AU2019234549A1 (en) *	2018-03-12	2020-10-08	Sqz Biotechnologies Company	Methods for treating HPV-associated diseases
WO2019210055A2 (en) *	2018-04-26	2019-10-31	Agenus Inc.	Heat shock protein-binding peptide compositions and methods of use thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4777239A (en) *	1986-07-10	1988-10-11	The Board Of Trustees Of The Leland Stanford Junior University	Diagnostic peptides of human papilloma virus
US5180806A (en) *	1988-05-16	1993-01-19	The Scripps Research Institute	Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods
US5932412A (en)	1990-05-11	1999-08-03	Euro-Diagnostica Ab	Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes
DE9106105U1 (de)	1991-05-17	1991-09-26	Behringwerke Ag, 3550 Marburg	Diagnose-Kit zum Nachweis von Human-Papillomavirusinfektionen
US6419931B1 (en)	1991-08-26	2002-07-16	Epimmune Inc.	Compositions and methods for eliciting CTL immunity
GB9505784D0 (en) *	1995-03-22	1995-05-10	Lynxvale Ltd	Anti-tumour treatment
CA2240834C (en) *	1995-12-22	2013-12-03	Immunomedics, Inc.	Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
ES2330017T3 (es)	1998-05-23	2009-12-03	Leiden University Medical Center	Ligandos de cd40 y peptidos de ctl para tratar tumores.
US20030118588A1 (en)	1999-05-22	2003-06-26	Linda Diehl	Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40
US6641994B2 (en)	1999-08-25	2003-11-04	Pharmacia & Upjohn Company	Methods of identifying anti-viral agents
US20020044948A1 (en) *	2000-03-15	2002-04-18	Samir Khleif	Methods and compositions for co-stimulation of immunological responses to peptide antigens
US7202034B2 (en) *	2000-12-08	2007-04-10	Academisch Ziekenhuis Leiden	Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
CN100335121C (zh) *	2001-07-20	2007-09-05	得克萨斯大学体系董事会	涉及hpv相关的癌前期的和癌的生长(包括cin)的方法和组合物
US6884605B2 (en)	2001-08-09	2005-04-26	Board Of Trustees Of The University Of Arkansas	Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer
EP1708745B1 (en)	2003-12-23	2012-04-18	Arbor Vita Corporation	Antibodies for oncogenic strains of hpv and methods of their use
EP1699479A1 (en) *	2003-12-24	2006-09-13	Leiden University Medical Center	Synthetic protein as tumor-specific vaccine
US8252893B2 (en)	2005-01-31	2012-08-28	Board Of Trustees Of The University Of Arkansas	CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
DE602006021408D1 (de) *	2005-04-27	2011-06-01	Univ Leiden Medical Ct	Behandlung von hpv-induzierter intraepithelialer anogenitaler neoplasien
AR054822A1 (es)	2005-07-07	2007-07-18	Sanofi Pasteur	Emulsion inmuno adyuvante

2008
- 2008-05-27 MX MX2009012922A patent/MX2009012922A/es active IP Right Grant
- 2008-05-27 ES ES08753797.3T patent/ES2482192T3/es active Active
- 2008-05-27 JP JP2010510239A patent/JP2010530362A/ja active Pending
- 2008-05-27 BR BRPI0812311A patent/BRPI0812311A8/pt not_active IP Right Cessation
- 2008-05-27 CN CN200880101172A patent/CN101795705A/zh active Pending
- 2008-05-27 EP EP08753797.3A patent/EP2155240B1/en not_active Not-in-force
- 2008-05-27 CA CA002688589A patent/CA2688589A1/en not_active Abandoned
- 2008-05-27 AU AU2008269721A patent/AU2008269721B2/en not_active Ceased
- 2008-05-27 WO PCT/NL2008/050315 patent/WO2009002159A2/en active Application Filing
- 2008-05-27 US US12/451,983 patent/US9562075B2/en not_active Expired - Fee Related
2014
- 2014-06-27 JP JP2014133168A patent/JP5888823B2/ja not_active Expired - Fee Related
2016
- 2016-12-16 US US15/381,367 patent/US20170143818A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20170143818A1 (en)	2017-05-25
ES2482192T3 (es)	2014-08-01
AU2008269721B2 (en)	2013-01-10
JP2010530362A (ja)	2010-09-09
BRPI0812311A8 (pt)	2019-02-05
CN101795705A (zh)	2010-08-04
CA2688589A1 (en)	2008-12-31
US20100196353A1 (en)	2010-08-05
EP2155240B1 (en)	2014-04-30
MX2009012922A (es)	2010-07-05
JP5888823B2 (ja)	2016-03-22
US9562075B2 (en)	2017-02-07
AU2008269721A1 (en)	2008-12-31
WO2009002159A2 (en)	2008-12-31
EP2155240A2 (en)	2010-02-24
WO2009002159A3 (en)	2009-02-12
JP2014185179A (ja)	2014-10-02

Publication	Publication Date	Title
BRPI0812311A2 (pt)	2014-10-29	Uso de um peptídeo derivado da proteína e2, e6 e/ou e7 do hpv
DK2061886T3 (da)	2014-08-11	Små kationiske immunomodulerende peptider
BRPI0818288A2 (pt)	2015-04-14	Proteínas conjugadas e peptídeos.
BRPI0819299A2 (pt)	2014-10-07	Uso de composição, e, composição contendo proteína
BRPI0922708A2 (pt)	2018-11-06	peptídeos mini-hepcidina e métodos de uso do mesmo
BRPI0907363A2 (pt)	2015-08-18	Métodos e composições relativos a peptídeos e proteínas com elementos de c-terminal
BRPI0913216A2 (pt)	2016-01-19	uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus.
BRPI0811637A2 (pt)	2014-11-18	Proteínas de fusão da imunoglobina
BRPI0820342A2 (pt)	2015-05-26	Modulação de tráfego de proteína
BRPI0924177A2 (pt)	2015-08-18	Polipeptídeos, seu método de preparação, sua composição, sequência de nucleotídeo e uso
BRPI0909084A2 (pt)	2015-08-11	Composição líquida, e, composto de peptídeo.
BRPI0822219A2 (pt)	2014-11-04	Ácidos nucléicos de aminotransferase e oxidoreductase e polipeptídeos e métodos de uso.
WO2011047087A3 (en)	2011-08-18	Protein detection via nanoreporters
DK1984517T3 (da)	2012-11-26	Fremgangsmåde til modulering af rekombinante proteiners mannoseindhold
BRPI1006134A2 (pt)	2016-02-23	anticorpo ou um fragmento funcional do anticorpo, composição farmacêutica, uso de um anticorpo ou um fragmento funcional do mesmo, polinucleotídeo, vetor, e, célula hospedeira transformada.
BRPI0814420A2 (pt)	2015-11-17	composição, e, uso de álcool alcoxilado.
CU23869B1 (es)	2013-03-27	Anticuerpos anti-esclerostina y proteínas funcionales
EP2185574A4 (en)	2010-11-17	ANTIBODIES AND RELATED MOLECULES THAT BIND PROTEINS 24P4C12
BRPI0919014A2 (pt)	2015-12-01	composição fixadora de cabelo, e, uso de uma composição
DK2046826T3 (da)	2011-10-24	Exendin-fusionsproteiner
BRPI0918027A2 (pt)	2015-12-01	enzimas de lise de peptidoglicano artificial e proteínas de ligação de peptidoglicano
BRPI0821995A2 (pt)	2015-06-23	Dispositivo de controle de fluido, e, anel de vedação
BRPI0906478A2 (pt)	2015-11-24	anticorpo anti-nr10 e uso do mesmo
BRPI0806589A2 (pt)	2014-05-13	Catalisador, sua preparação e uso.
ATE518958T1 (de)	2011-08-15	Zur impfung verwendetes papillomavirus-e2- polypeptid

Legal Events

Date	Code	Title	Description
2015-10-13	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-11-27	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-02-05	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-03-26	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 11A ANUIDADE.
2019-07-16	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2516 DE 26-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.
2022-07-12	B350	Update of information on the portal [chapter 15.35 patent gazette]